Global commerce is at the mercy of the current COVID-19 pandemic. Firms’ must operate with the flexibility to cope with supply lines disruptions, port back-ups, and the availability of employees who can or will work.

Global commerce is at the mercy of the current COVID-19 pandemic. Firms’ must operate with the flexibility to cope with supply lines disruptions, port back-ups, and the availability of employees who can or will work.

FDA’s import program is complex, detailed, and changes without notice to the public. The FDA’s and CBP’s new import and enforcement programs operate with remarkable efficiency using software systems.

If an entry is detained, that will leave a firm scrambling for a resolution or suffer expensive consequences. If the FDA detains your shipment, you must resolve the problem under a 10-day deadline. On day 11, your product must either be destroyed or exported. That means you need to know the basic information and procedural requirements to avoid costly charges and fines.

Learning Objectives:-

• Identify and mitigate the impact factors of COVID-19
• Understand how the FDA’s and the CBP’s legal and administrative requirements intersect such as the Affirmation of Compliance and ACE
• Know fundamental information required for entry
• Understand FDA’s internal procedures
• Learn how to mitigate and resolve import detentions

Areas Covered in the Session:-

• Impact of COVID-19
• Information required by FDA, CBP, and the U.S. Census Bureau
• FDA’s entry procedures
• Resolving import detentions
• Foreign supplier requirements

Who Will Benefit:-

• Business Planning Executives
• Regulatory Directors
• In-house Legal Counsel and Contract Specialists
• Venture Capitalists
• Business acquisition Managers
• Owners of New or Developing Import/Export Firms
• International Trade and Logistics Managers
• Import Brokers
• Investors
• Sales Managers